Svensson C K, Knowlton P W
Department of Pharmaceutical Sciences, College of Pharmacy & Allied Health Professions, Wayne State University, Detroit, Michigan 48202.
Pharm Res. 1989 Jun;6(6):477-80. doi: 10.1023/a:1015964306318.
Interferon and interferon inducers have been found to inhibit cytochrome P-450-dependent metabolism in animals and man. The effect of these agents on the acetylation of drugs has not been previously reported. Since these agents stimulate the reticuloendothelial system, together with the abundance of N-acetyltransferase in the reticuloendothelial system, it was hypothesized that these immunomodulators may affect drug acetylation. To test this hypothesis, the effect of tilorone (a synthetic interferon inducer) on the in vivo acetylation of procainamide was examined in the rat. Pretreatment with tilorone hydrochloride (50 mg/kg) 48 hr prior to the administration of procainamide hydrochloride (50 mg/kg) resulted in a 32% increase in the urinary recovery of N-acetylprocainamide and a 35% increase in the metabolic clearance of procainamide to N-acetylprocainamide. These data indicate that interferon inducers increase the N-acetylation of drugs in vivo.
干扰素和干扰素诱导剂已被发现可抑制动物和人体中细胞色素P-450依赖性代谢。这些药物对药物乙酰化的影响此前尚未见报道。由于这些药物刺激网状内皮系统,且网状内皮系统中存在大量N-乙酰转移酶,因此推测这些免疫调节剂可能会影响药物乙酰化。为验证这一假设,在大鼠中研究了泰洛龙(一种合成干扰素诱导剂)对普鲁卡因胺体内乙酰化的影响。在给予盐酸普鲁卡因胺(50mg/kg)前48小时,用盐酸泰洛龙(50mg/kg)预处理,导致N-乙酰普鲁卡因胺的尿回收率增加32%,普鲁卡因胺向N-乙酰普鲁卡因胺的代谢清除率增加35%。这些数据表明,干扰素诱导剂可增加体内药物的N-乙酰化。